Adaptive Biotechnologies Corporation
ADPT
$12.63
$0.3352.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 36.33% | 25.24% | 3.66% | 22.46% | -11.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.33% | 25.24% | 3.66% | 22.46% | -11.72% |
| Cost of Revenue | -5.68% | -5.94% | 16.24% | -14.72% | -10.92% |
| Gross Profit | 1,231.49% | 48.87% | -7.05% | 156.28% | -21.21% |
| SG&A Expenses | 8.24% | -3.51% | -7.04% | -6.80% | -17.25% |
| Depreciation & Amortization | -0.24% | -0.95% | -0.23% | 0.00% | 0.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.73% | -9.48% | -11.08% | -11.04% | -13.89% |
| Operating Income | 37.59% | 39.29% | 25.86% | 35.96% | 16.11% |
| Income Before Tax | 44.66% | 37.24% | 51.46% | 36.22% | 3.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.66% | 37.24% | 51.46% | 36.22% | 3.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -180.77% | -184.62% | -3.85% | 0.00% | 2,500.00% |
| Net Income | 44.58% | 37.16% | 51.48% | 36.24% | 3.32% |
| EBIT | 37.59% | 39.29% | 25.86% | 35.96% | 16.11% |
| EBITDA | 41.52% | 42.88% | 26.98% | 37.95% | 16.73% |
| EPS Basic | 46.30% | 38.60% | 52.40% | 37.46% | 5.29% |
| Normalized Basic EPS | 36.34% | 39.93% | 26.57% | 37.48% | 20.06% |
| EPS Diluted | 46.30% | 38.60% | 52.40% | 37.46% | 5.29% |
| Normalized Diluted EPS | 36.34% | 39.93% | 26.57% | 37.48% | 20.06% |
| Average Basic Shares Outstanding | 3.17% | 2.34% | 1.92% | 1.94% | 2.09% |
| Average Diluted Shares Outstanding | 3.17% | 2.34% | 1.92% | 1.94% | 2.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |